Results 181 to 190 of about 50,514 (354)

Interferon regulatory factor�3 mediates Poly(I:C)-induced innate immune response and apoptosis in non‑small cell lung cancer

, 2018
Yi Liang, Dan Sun, Qian Han, Zhonghui Liu, Zeng Zeng, Yanping Wu, Xiaoyu Chai, Xinmin Liu   +7 more
openalex   +2 more sources

T Cell Glycoengineering to Modulate Immune‐Tumor Crosstalk: A Universal Non‐Genetic Strategy for Enhanced Tumor Immunotherapy

Advanced Science, EarlyView.
This study describes a T cell surface engineering strategy that integrates polymer materials with tumor immunology, aiming to achieve broad‐spectrum anti‐tumor applications of glycopolymer‐engineered T (G‐T) cells via non‐genetic modification. Glycopolymer engineering generally modulates immune‐tumor crosstalk through specific cell‐cell interactions ...
Lihua Yao, He Yang, Fangjian Shan, Xiaomeng Niu, Yichen Wang, Hengyuan Zhang, Sujian Wang, Gaojian Chen, Hong Chen   +8 more
wiley   +1 more source

Interferon-Induced Mania [PDF]

The Canadian Journal of Psychiatry, 2004
Asif R Malik, Saj Ravasia
openaire   +1 more source

Pioneering Role of T.C. Merigan in the Treatment of Various Virus Infections. [PDF]

Molecules
De Clercq E.
europepmc   +1 more source

Ferret Interferon (IFN)-Inducible Transmembrane Proteins Are Upregulated by both IFN-α and Influenza Virus Infection

, 2021
William S. J. Horman, Katherine Kedzierska, Christina L. Rootes, Andrew G. D. Bean, Thi H. O. Nguyen, Daniel Layton   +5 more
openalex   +2 more sources

Interferon‐Driven Biomarkers and Synergistic Therapy for PRMT5 Inhibition in Triple‐Negative Breast Cancer

Advanced Science, EarlyView.
Triple‐negative breast cancer exhibits variable sensitivity to PRMT5 inhibition. Basal interferon signaling is identified as a key biomarker of response. PARP inhibition with olaparib induces IFN signaling, sensitizing resistant TNBC cells to PRMT5 inhibitors.
Ziwen Zhang, Sheyu Zhang, Lu Guo, Yichun Pan, Juan Huang, Yishuai Ji, Jiaqi Tao, Yong Wei, Xiaojia Wang, Qin Wu   +9 more
wiley   +1 more source

FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancer. [PDF]

Oncoimmunology
Kepp O, Kroemer G.
europepmc   +1 more source

In vitro sensitivity testing of human renal cell carcinoma with cytostatic agents and interferon alpha-2a [PDF]

, 1991
AC Buzaid, AR Hanauske, AW Hamburger, C. G. Stief, DD Hoff Von, DT Harris, E. Allhoff, G Kovacs, G. Lenis, HB Muss, J Gerdes, J Gerdes, J Gerdes, J Rinehart, JB Kernion de, JL Cordell, JP Bergerat, JU Gutterman, LD Leder, M Albrecht, MM Lieber, P. Anton, PHM Mulder de, R. Schlick, RT Oliver, S. Liedke, SD Fossa, U. Jonas, W Riese de, W Riese de, W. de Riese, WH Davis, WJ Hrushesky   +32 more
core   +1 more source

Inhibition of Hypersialylation in Human Intervertebral Disc Degeneration Modulates Inflammation and Metabolism

Advanced Science, EarlyView.
Glycosylation, specifically hypersialylation, is identified as a critical factor in human intervertebral disc (IVD) degeneration—a major cause of low back pain. This study demonstrates that inhibiting sialylation reduces inflammation and oxidative stress in IVD tissues, suggesting new therapeutic possibilities.
Kieran Joyce, Aert F. Scheper, Aung Myat Phyo, Roisin O’ Flaherty, Richard Drake, Aiden Devitt, Martina Marchetti‐Deschmann, Radka Saldova, Abhay Pandit   +8 more
wiley   +1 more source

Interferon and Interferon Inducers: Clinical Applications [PDF]

Pathology, 1981
openaire   +2 more sources